Position in LLY
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$7,023,862
+$1,691,036 QoQ
Shares Held
5,856
+1.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.26%
of 13F equity value
Holder Rank
#1,471
of 4,605 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Arista Wealth Management, LLC holds $17,740,479 across 10 Drug Manufacturers - General names. LLY ranks #1 (39.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
5,856 | $7,023,862 | |
| 2 | ABBV |
AbbVie Inc.
|
11,815 | $2,973,126 | |
| 3 | JNJ |
Johnson & Johnson
|
9,713 | $2,466,810 | |
| 4 | PFE |
Pfizer Inc
|
71,676 | $1,725,958 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
7,898 | $997,833 | |
| 6 | MRK |
Merck & Co., Inc.
|
6,551 | $841,803 | |
| 7 | AZN |
Astrazeneca PLC
|
2,536 | $480,876 | |
| 8 | NVO |
Novo Nordisk A S
|
10,000 | $479,400 |
All Filings in LLY
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,023,862 | 5,856 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $5,332,826 | 5,798 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $6,183,709 | 5,754 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $4,613,861 | 6,047 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $4,346,659 | 5,576 | Shares | Sole | 2025-07-29 | |
| No filing history on record for this holder in this stock. | ||||||